Moderna struggles with vaccine ramp-up, cuts 2021 sales view
Moderna Inc on Thursday (Nov 4) slashed the 2021 sales forecast for its Covid-19 vaccine by as much as $5 billion (S$6.7 billion), grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16 per cent. Moderna executives said production challenges now lie with bottling up doses, also known as...